BMTs and PBSCTs are most commonly used for treating patients who have leukemia, lymphoma or multiple myeloma (cancer involving plasma cells, a type of white blood cell), but they also can be used to treat other cancers, such as neuroblastoma (cancer involving immature nerve cells) and several other malignant and nonmalignant conditions.